Promino Announces Proposed Private Placement

Core Viewpoint - Promino Nutritional Sciences Inc. plans to conduct a non-brokered private placement to raise up to $1,200,000 through the issuance of 40,000,000 units at a price of $0.03 per unit, with each unit consisting of one common share and one half of a common share purchase warrant [1][2]. Group 1: Offering Details - The offering will consist of units priced at $0.03 each, with each unit including one common share and one half of a warrant, where each whole warrant can purchase an additional share at $0.06 for twelve months [1]. - The expected closing date for the offering is around April 15, 2026, subject to regulatory approvals and execution of subscription agreements [3]. - All securities issued will have a resale restriction of four months and one day as per Canadian securities laws [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated to inventory production and general corporate purposes, excluding salaries for officers or directors and payments for investor relations activities [2]. Group 3: Company Overview - Promino Nutritional Sciences is a Canadian company focused on science-based nutrition for muscle health, with its core product being Rejuvenate Muscle Health™, a clinically researched amino acid formula [5]. - The company also produces Promino™, which is NSF Certified for Sport® and is endorsed by elite athletes [6].